The lawsuits, filed earlier this year, claimed athenahealth failed to disclose how it arrived at the sale price of $5.7 million — the figure private equity firm Veritas Capital and Elliott Management affiliate Evergreen Coast Capital agreed to pay for the company in November.
According to one of the lawsuits, athenahealth failed to disclose the financial projections it relied upon to arrive at the cost of the sale, as well as any potential conflicts of interest. That complaint was brought under a section of the Securities Exchange Act, which requires companies provide shareholders with a definitive proxy statement that helps ensure shareholders’ rights are upheld during a merger or acquisition.
Becker’s Hospital Review reached out to athenahealth for comment. This article will be updated as more information becomes available.
More articles on EHRs:
Nebraska pediatrics hospital to go live on Meditech EMR
AHA, 6 other hospital groups release interoperability agenda
HITECH should require mental health providers to adopt EHRs too, report says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
